BIOMAT Database Logo BIOMAT Database Logo

Acceleration of hemopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells. 1991

M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
INSERM U76, CHU Saint-Antoine, Paris, France.

Twenty patients with advanced malignant disease submitted to autologous bone marrow transplantation with marrow either unpurged (10 patients) or purged in vitro with mafosfamide (10 patients) after ablative chemotherapy, received simultaneously autologous peripheral blood stem cells (PBSC) collected during one to three 3 h cytapheresis procedures. The kinetics of the hematological recovery of these patients were compared to those of a group of patients suffering from similar diseases and grafted in the same institution with either unpurged marrow only (14 patients) or purged in vitro with mafosfamide (six patients). The median times to reach 10(9)/l leukocytes, 0.5 x 10(9)/l polymorphs, and 50 x 10(9)/l platelets were reduced by 10, 10, and 13 days, respectively, in patients transfused with both autologous bone marrow and peripheral blood stem cells as compared to those receiving bone marrow only. A reduction in the numbers of days spent in hospital post-transplantation (p less than 0.01), of days of fever greater than 38 degrees C (p = NS), and of platelet (p = 0.07) and of red blood cell transfusions (p less than 0.01) were also observed in the group of patients grafted with bone marrow and PBSC.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001773 Blood Cells The cells found in the body fluid circulating throughout the CARDIOVASCULAR SYSTEM. Blood Corpuscles,Blood Cell,Blood Corpuscle,Cell, Blood,Cells, Blood,Corpuscle, Blood,Corpuscles, Blood
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
Use of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantation.
January 1990, Haematologica,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
Peripheral blood stem cells as a source for hemopoietic recovery following autologous bone marrow transplantation in childhood malignancy.
August 1994, Israel journal of medical sciences,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
Immune recovery after bone marrow and peripheral blood stem cells transplantation.
September 1999, Transplantation proceedings,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
[Cryopreservation of hemopoietic stem cells in autologous bone marrow transplantation].
January 1989, Ugeskrift for laeger,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
[Immune reconstitution after autologous progenitor hemopoietic cell transplantation. A study comparing autologous bone marrow and autologous peripheral blood transplantation].
June 1998, Medicina clinica,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
Fractionated total body irradiation and autologous bone marrow transplantation in dogs: hemopoietic recovery after various marrow cell doses.
April 1980, Experimental hematology,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
Peripheral blood stem cells used to augment autologous bone marrow transplantation.
March 1994, Archives of disease in childhood,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
Recovery of blood and bone marrow stem cells following intense chemotherapy and autologous bone marrow transplantation.
January 1986, Oncology,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: comparison of bone marrow and peripheral blood progenitor cells.
August 1996, Leukemia & lymphoma,
M Lopez, and O Mortel, and P Pouillart, and J M Zucker, and J Fechtenbaum, and L Douay, and T Palangie, and J Michon, and D Salmon, and N C Gorin
Peripheral blood stem-cell transplantation versus non-cryopreserved autologous bone-marrow transplantation.
January 1993, Lancet (London, England),
Copied contents to your clipboard!